Global Cell Line Development Market 2017-2021
About Cell Line Development
Cell line development is the process by which prokaryotic (bacteria, virus, protozoa) and eukaryotic (animals, plants) cells are allowed to grow under precise conditions. But in practice, cell line development is generally derived from animal cells which includes mammals, insects and amphibians. The cells are removed from tissue and separated through enzymatic or mechanical process which is further used for cultivation.
Technavio’s analysts forecast the global cell line development market to grow at a CAGR of 12.27% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global cell line development market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sale of cell line development system.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Cell Line Development Market 2017-2021
Technavio recognizes the following companies as the key players in the global cell line development market: GE Healthcare, Lonza, Merck Millipore, and Thermo Fisher Scientific.
Other Prominent Vendors in the market are: Cobra Biologics, Corning, Molecular Devices, Sartorious, SELEXIS, and WuXi Biologics.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is increase demand for regenerative medicine. Regenerative medicine, a branch of medicine develops process to regrow, repair and replace damaged and diseased cells, tissues, and organs. This is done by the use of therapeutic stem cells lines, the production of artificial organs, and tissue engineering.”
According to the report, one driver in the market is increased demand for monoclonal antibodies. A monoclonal antibody is a type of protein which is developed in laboratory for binding to substances in the body such as cancer cells. It binds to only one kind of substance so at present there are many kinds of monoclonal antibodies which are used as therapeutic agents such as treatment of different types of cancer. They are either used alone or in conjugation with drugs, radioactive substances or toxins to kill the diseased cells.
Further, the report states that one challenge in the market is development of authentic cell lines. Various cell lines which have large application in biomedical research have become contaminated due to overgrown by other more aggressive cells and become cross-contaminated. For instance, probably thyroid cell lines were actually melanoma cells, prostate tissues were actually bladder cancer cells and these contaminated cell lines are easily used in research without prior knowledge of their true character because they are not differentiated on the basis of physical appearance.
GE Healthcare, Lonza, Merck Millipore, Thermo Fisher Scientific, Cobra Biologics, Corning, Molecular Devices, sartorious, SELEXIS, and WuXi Biologics.